Boston Globe reporter Martin Finucane writes that MIT researchers have developed an ingestible capsule that contains a small needle that injects insulin directly into the stomach. Finucane writes that the researchers “designed the pill with a special shape to ensure that it will fall and then orient itself at the bottom of the stomach so that the needle is facing toward the stomach lining rather than the stomach’s inside.”
Forbes contributor Angelica Krystle Donati highlights a recent presentation by Prof. Robert Langer, in which he shared his experience founding more than 40 startups.
MIT researchers have developed an inhalable form of messenger RNA that could be used to help treat patients with lung disease, reports Christopher Intagliata for Scientific American. Intagliata explains that researchers hope to one day “use this technique to help cystic fibrosis patients.”
MIT researchers have developed a remote-controlled ingestible capsule that can be operated by a user’s smartphone, reports the Xinhua news agency. “The researchers envisioned that this type of sensor could be used to diagnose early signs of disease and then respond with the appropriate medication,” Xinhua explains.
HealthDay News reporter E.J. Mundell writes that MIT researchers have developed an ingestible capsule that can be used to monitor health a patient’s health. “The capsule could deliver drugs as well as sense the condition of its surroundings in the gut, including infections or allergic reactions,” Mundell explains.
MIT researchers have developed a new injectable material that can deliver medication through cartilage and could one day be used to help reverse osteoarthritis, reports Katie Camero for The Boston Globe. Camero explains that the new material “can penetrate deep into the tissue, delivering drugs that can potentially help the chondrocytes heal cartilage.”
STAT reporter Kate Sheridan writes about MIT startup SQZ Biotech, which is developing a “technology that will squeeze cells to open up tiny pores in their membranes to deliver gene therapies or medicines straight into the cell.”
MIT startup Lyndra has found that an ingestible device originally developed by researchers from MIT and Brigham and Women’s Hospital can help tackle the problem of medication adherence, reports Kate Sheridan for STAT. The new technology could make it possible for patients to take “one pill a week for conditions as varied as Alzheimer’s, addiction, allergies, malaria, schizophrenia, high cholesterol, and HIV.”
Writing for the American History Magazine, Sarah Richardson highlights the trailblazing path of Ellen Swallow Richards. Richardson notes that Swallow Richards was a “one-woman parade of firsts: first female student at Massachusetts Institute of Technology, first female fellow of the American Association of Mining and Metallurgy, first female professor at MIT.”
Researchers from MIT are using the brittle nature of graphene to mass produce cell-sized robots, writes David Grossman of Popular Mechanics. Called “syncells” or synthetic cells, the researchers hope they can be used in biomedical testing. “Inject hundreds into the bloodstreams and let the data fly back into sensors,” explains Grossman.
A team of researchers led by Prof. J. Christopher Love has developed a system to produce on-demand clinical-grade vaccines and drugs, writes Dr. Francis Collins on the NIH Director’s Blog. In addition to allowing on site production for hospitals the systems could also “produce biologic treatments specially tailored to attack the cancer of a particular individual,” suggests Collins.
Writing for STAT, Karen Weintraub spotlights Prof. J. Christopher Love’s work developing a new desktop drug manufacturing process that can produce thousands of doses of biopharmaceuticals on demand. “I think in the long run there’ll be an opportunity to think about manufacturing for patients in a new way,” says Love.
Xinhua news wire reports that MIT researchers have developed a tiny new robot, the size of a human egg cell, that could be used to detect medical problems or to identify oil or gas leaks. “The self-powered cell-size robots don't need any external power source or even internal batteries,” explains Xinhua.
MIT researchers have designed new robots the size of a human egg cell that can sense their surroundings, writes Brooks Hays for UPI. These nanoscale robots could one day be used to develop less invasive colonoscopies or aid in the search for structural vulnerabilities inside oil and gas pipelines, explains Hays.
TechCrunch reporter Brian Heater writes that MIT researchers have developed self-powered robots the size of human cells that can float indefinitely in liquid or the air. Heater explains that the robots could be used to monitor hard to reach environments, such as pipelines or the human body.